Quantcast

Latest immunotherapy Stories

2014-08-19 12:28:17

SYDNEY, Aug. 19, 2014 /PRNewswire/ -- Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) ("Prima", the "Company") today announced that the abstract entitled, "Trial evaluating overall survival in epithelial ovarian cancer (EOC) patients in second remission with an autologous dendritic cell therapy targeting mucin 1" has been accepted for a poster presentation at the Society for Immunotherapy of Cancer ("SITC") 29th Annual Meeting. The poster will be presented by Prima's...

2014-08-11 23:01:33

Darst and Landes – both of whom lost mothers to cancer – will connect with a younger demographic. Stamford, CT (PRWEB) August 11, 2014 Alliance for Cancer Gene Therapy, Inc. (ACGT) – the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer – has announced that David Darst and Alexandra Landes have joined the foundation’s Board of Directors. Both Darst and Landes lost their mothers to cancer and share a commitment to uncovering innovative methods...

2014-08-11 08:29:29

HPV Immune Therapy VGX-3100 to Advance into Phase III PLYMOUTH MEETING, Penn., Aug. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. Total operating expenses were $14.0 million and $26.3 million for the three and six months...

2014-08-11 08:28:16

TAMPA, Fla., Aug. 11, 2014 /PRNewswire/ -- Morphogenesis Inc., the Tampa-based biotech company that developed the ImmuneFx(TM) cancer vaccine for dogs, cats and horses, announces that it has chosen Florida Veterinary Referral Center & 24-Hour Emergency Hospital in Estero, FL, as the newest exclusive provider of the ImmuneFx(TM) therapy process for companion animals. ImmuneFx(TM) primes and educates the pet's own immune system to recognize and kill cancer cells without harming...

2014-08-06 12:28:13

Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the Antigen Express Novel Immunotherapeutic AE37 WORCESTER, Mass. and TORONTO, Aug. 6, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical trial of the immunotherapeutic agent AE37 in patients with prostate cancer. The study demonstrates an association between a specific immune...

2014-08-05 08:33:51

Total Investment Tops $300M in Less Than 12 Months SEATTLE, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, Inc., a biotechnology company focused on bringing forward novel immunotherapies for cancer, today announced that it has closed its Series B round with $134M in new investment. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO This latest round includes new investments by ten public mutual funds and healthcare-focused funds. All major prior investors...

2014-08-05 08:32:08

MONMOUTH JUNCTION, N.J., Aug. 5, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced distribution of its CytoSorb(®) extracorporeal cytokine adsorber in Taiwan through an exclusive agreement with Hemoscien Corporation. This multi-year agreement is subject to annual minimum guaranteed orders of CytoSorb(®) to maintain exclusivity....

2014-07-31 08:35:47

Conference Call on Thursday, August 7, 2014 LAWRENCEVILLE, N.J., July 31, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its second quarter 2014 financial results at 11:00 a.m. EDT on Thursday, August 7, 2014. To participate in the call, interested parties may dial 1-800-533-7954 (Toll-Free/North America) or 1-785-830-1924 (International/Toll) and ask for the Celsion Corporation Second Quarter 2014...

2014-07-30 23:10:37

OMICS International is delighted to announce the 4th World Congress on Cancer Science & Therapy during August 20th-22nd, 2014 at Chicago, USA with the theme “Enhanced diagnosis, treatment and management of different cancers.” Los Angeles, CA (PRWEB) July 30, 2014 Cancer Therapy-2014 will be an unique platform, which will bring together the renowned oncologists, scientists and scholars in pursuit of unraveling the mysteries of cancer under one roof. In the Keynote forum of Cancer...

2014-07-28 23:06:36

Dust mite allergies tend to spike in July and August. While there are a number of measures allergy sufferers can take to limit their exposure to dust, it is often more advantageous to get treatment for dust allergies and AllergyEasy offers a "no-shots" treatment that's safer and more convenient than shots. Mesa, AZ (PRWEB) July 28, 2014 For those with dust allergies, home can be a miserable place. Dust mites—a prime cause of dust allergies—commonly settle in mattresses,...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.